Information  X 
Enter a valid email address

Byotrol PLC (BYOT)

  Print          Annual reports

Monday 27 September, 2021

Byotrol PLC

Posting of Annual Report & Accounts/Notice of AGM

RNS Number : 1180N
Byotrol PLC
27 September 2021



Byotrol plc ("Byotrol" or the "Company")

Posting of Annual Report & Accounts and Notice of AGM


Byotrol announces that it has today posted to shareholders the Annual Report & Accounts for the year ended 31 March 2021 as well as a notice of the Annual General Meeting ("AGM"), which is currently planned to be open to shareholders and will be held at 11.00 a.m. on 20 October 2021 at the offices of finnCap Ltd at One Bartholomew Close, London, EC1A 7BL.

A copy of the Annual Report & Accounts and the notice of AGM will shortly be available on the Company's website at .






Byotrol plc 

David Traynor - Chief Executive Officer

Nic Hellyer - Chief Financial Officer    01925 742 000



Geoff Nash/Kate Bannatyne - Corporate Finance                                020 7220 0500

Richard Chambers - ECM


Flagstaff Strategic and Investor Communications

Tim Thompson/Andrea Seymour/Fergus Mellon   020 7129 1474

[email protected]




Notes to Editors:


Byotrol plc (BYOT.L), quoted on AIM, is a leading anti-microbial technology company, operating globally in the Food, Industrial, Healthcare and Consumer sectors, providing low toxicity products with a broad-based and long-lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, mycobacteria and algae.


Powerful, long-lasting and gentle, Byotrol's products can be used stand-alone or as ingredients within existing products, where Byotrol can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.


Founded in 2005, the Company develops technologies that create easier, safer and cleaner lives for everyone. 


For more information, please go to


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t